Navigation Links
P&G Reports Accelerated Sales and Unit Volume Growth
Date:1/28/2010

CINCINNATI, Jan. 28, 2010 /PRNewswire-FirstCall/ -- The Procter & Gamble Company (NYSE: PG) delivered net sales growth of six percent for the October - December quarter to $21.0 billion.  Organic sales grew five percent which was at the top of the Company's guidance range.  Diluted net earnings per share were $1.49 and diluted net earnings per share from continuing operations were $1.01.  Core EPS increased 22 percent to $1.10 for the quarter, above the Company's guidance range, on better than expected sales growth and margin expansion.  The Company raised its expectations of fiscal 2010 organic sales growth and Core EPS.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090115/CLTH035LOGO-a)

"We are pleased with the top- and bottom-line underlying results for the quarter," said Chairman of the Board, President and Chief Executive Officer Bob McDonald.  "Our investments in innovation, portfolio expansion, marketing support and consumer value are working.  We continue to drive simplification and leverage our scale to create cost advantages and accelerate growth.  While economic uncertainty remains, we're confident these strategies will enable P&G to serve more consumers in more parts of the world, more completely and deliver profitable market share growth."  

Executive Summary

    '/>"/>

SOURCE Procter & Gamble
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine technology :

1. P&G Voluntarily Recalls DayQuil Cold & Flu 24-Count LiquiCaps
2. Warner Chilcott Completes Acquisition of P&Gs Global Branded Prescription Pharmaceuticals Business
3. Bob McDonald Outlines Key Long Term Growth Strategies To P&G Shareholders
4. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635
5. Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results
6. Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010
7. Helix BioPharma Reports On 2009 Annual General Meeting
8. Solos Endoscopy, Inc. Reports Sales Increase for October 2009 and November 2009 as Compared to Same Two Months in 2008
9. Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase
10. Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging
11. ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-ENs Effectiveness in Maintaining Remission in Patients with Crohns Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... , Sept. 22, 2014  Elusys Therapeutics, ... to treat infectious disease, today announced it has ... studies of obiltoxaximab (ETI-204). Obiltoxaximab is an anti-toxin ... and data from these studies support the safety ... (IV) at the intended therapeutic dose. The conclusion ...
(Date:9/22/2014)...  Aethlon Medical, Inc. (OTCQB: AEMD), the pioneer ... disease, cancer and other life-threatening conditions, disclosed today ... has informed the Company that it plans to ... of a five-year $5.9 million contract that was ... DARPA,s Dialysis-Like Therapeutics (DLT) program. The ...
(Date:9/22/2014)... 2014 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or ... quality medical marijuana products, is pleased to announce that ... signed a definitive lease agreement for a second facility ... facility has 28,966 square feet of floor space with ... mezzanine space for a total of approximately 43,500 square ...
Breaking Medicine Technology:Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 2Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 3Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 4Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 5Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 6Aethlon Medical Receives Notice of DARPA Contract Renewal 2Aethlon Medical Receives Notice of DARPA Contract Renewal 3Aethlon Medical Receives Notice of DARPA Contract Renewal 4T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 2T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 3
...  PAREXEL International Corporation (NASDAQ: PRXL ) today ... March 31, 2012. For the three months ... by 18.1% to $356.0 million compared with $301.4 million ... negative impact from foreign exchange on consolidated service revenue ...
... Mass., April 29, 2012  Haemonetics Corporation (NYSE: ... acquire the business assets of the blood collection, filtration ...  Blood processing systems and equipment to be acquired are ... facilities in Covina, California; Tijuana, Mexico; Ascoli, Italy and ...
Cached Medicine Technology:PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 2PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 3PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 4PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 5PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 6PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 7PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 8PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 9PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 10PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 11PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 12PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 13Haemonetics Signs Definitive Agreement to Acquire Pall Corporation's Blood Collection, Filtration and Processing Product Lines For $551 Million 2Haemonetics Signs Definitive Agreement to Acquire Pall Corporation's Blood Collection, Filtration and Processing Product Lines For $551 Million 3Haemonetics Signs Definitive Agreement to Acquire Pall Corporation's Blood Collection, Filtration and Processing Product Lines For $551 Million 4Haemonetics Signs Definitive Agreement to Acquire Pall Corporation's Blood Collection, Filtration and Processing Product Lines For $551 Million 5
(Date:9/23/2014)... Recently, BuyTopDress.com, a popular supplier of wedding dresses and special ... fashionable marine ball dresses . Along with this, the ... brand new items; all of them are now provided with ... now, BuyTopDress.com has won more than 2000 happy customers in ... its products and after-sale services. The company is offering thousands ...
(Date:9/22/2014)... September 23, 2014 The Gesundheit! Institute ... a new design and restructuring for their existing website. The ... grown. They needed a way to navigate to the different ... well as present the look and feel of the site ... In 1971, when Patch Adams graduated from The Medical School ...
(Date:9/22/2014)... leather seat covers offered by Lseat.com are meticulously in ... to meet customers’ specific product needs and budget level. The ... leather seat covers . Furthermore, the firm has launched an ... the new range is now available at a discounted rate ... are produced, the company’s top designers also carefully pick out ...
(Date:9/22/2014)... Career Step, an online provider of ... and exhibiting at the 86th Annual Convention and ... (AHIMA) in San Diego, California. The conference is ... Career Step will be exhibiting in booth 711 ... products, including CLiM™, its coder lifecycle management solution, ...
(Date:9/22/2014)... Marietta, GA (PRWEB) September 23, 2014 The ... staff are helping to promote National Breast Cancer Awareness ... intend to contribute awareness to cause, prevention, diagnosis, treatment and ... in dental offices across the U.S. , A pink ... the person that can tell us why the Sonicare is ...
Breaking Medicine News(10 mins):Health News:Fashionable Marine Ball Dresses Added To BuyTopDress.com’s Collection 2Health News:Idea Marketing Group Launches a New Website for The Gesundheit! Institute 2Health News:Idea Marketing Group Launches a New Website for The Gesundheit! Institute 3Health News:Great 2007-2012 Jeep Wrangler JK Real Leather Seat Covers Introduced by Lseat.com 2Health News:Career Step to Exhibit at AHIMA Convention September 27 through October 1 2Health News:Verde Pointe Dental Associates Participate in Breast Cancer Awareness Month 2014 with a Pink Philips Sonicare Giveaway 2
... ... workplace culture to empower professional women to breastfeed , ... Sacramento, CA (PRWEB) May 10, 2010 -- Is the primitive fear ... ,That is one premise a California startup, Dao Health, is contributing to the public conversation ...
... ill and participate in mild exercise programs led by ... days in intensive care units (ICU) and hospitals than ... published in the April issue of the Archives ... quality improvement project implemented in a medical intensive care ...
... physical abuse alone, study found , MONDAY, May 10 (HealthDay ... women who are exposed to physical and verbal abuse have ... up in the results, study author Dr. Charles P. Mouton ... physical abuse alone. , Why? "The physical abuse may be ...
... pressure are at even greater risk, study finds ... have fluctuating blood pressure in addition to high blood ... research shows. , Cerebrovascular disease, which includes stroke and ... associated with disability and a decline in memory and ...
... sibling has the movement disorder, study shows , MONDAY, May ... who have restless legs syndrome are also more likely to ... authors of the study, which is published in the May ... will raise awareness of the condition for both physicians and ...
... The lawsuit, ... some 30,000 health care workers, treats visiting nurses and other health care providers as exempt ... hours worked. , ... NY (PRWEB) May 10, 2010 -- A nationwide class action lawsuit was filed ...
Cached Medicine News:Health News:Is Fear of Being Caught Naked an Obstacle to Increasing Breastfeeding Rates? 2Health News:Is Fear of Being Caught Naked an Obstacle to Increasing Breastfeeding Rates? 3Health News:Is Fear of Being Caught Naked an Obstacle to Increasing Breastfeeding Rates? 4Health News:Physical therapist-led exercise in patients in ICU improves function and decreases hospital stay 2Health News:Older, Abused Women Suffer Poor Mental Health 2Health News:Fluctuating Blood Pressure Ups Stroke Risk 2Health News:Restless Legs Syndrome Can Have Family Ties 2Health News:Martin & Jones Announces Class Action Lawsuit Against Major Employer, Claims Thousands of Visiting Nurses Illegally Denied Overtime Pay 2Health News:Martin & Jones Announces Class Action Lawsuit Against Major Employer, Claims Thousands of Visiting Nurses Illegally Denied Overtime Pay 3
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTP/1Q-PAL chairs are recommended for the ... room, static control, health care and ...
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTP/1Q-PAL chairs are recommended for the ... room, static control, health care and ...
... with concave seats and standard-sized backrests ... like seats, backrests, armrests, and casters ... recommended for the following environments: industry, ... health care and office. • With ...
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTN/1Q-CAB chairs are recommended for the ... room, static control, health care and ...
Medicine Products: